Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat ...

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable ...

Christel Nielsen receives funding from The Swedish Research Council for Sustainable Development, The Crafoord Foundation, and The Magnus Bergvall Foundation. Can tattoos protect your skin from the sun ...

Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make immune-based treatments far more powerful. They found that tumors use a ...

Japanese researchers discovered that hair graying and melanoma share a surprising cellular origin. When DNA damage strikes melanocyte stem cells, they may undergo a protective process called ...

Please provide your email address to receive an email when new articles are posted on . New treatments for lung cancer and melanoma have significantly improved OS, but also have exacerbated ...

In the fight against cancer, an important field of research is the search for safe alternatives to chemotherapy and radiotherapy. These treatments attack both cancer cells and healthy cells, exposing ...

A form of T-cell therapy targeting a highly expressed antigen in uveal melanoma, a rare form of the disease, appears to be tolerable and efficacious, even though the tumors are considered to be ...

Weekend mornings anchor, CBS New York; Correspondent, CBS News and Stations Elaine Quijano is a weekend mornings anchor for CBS New York and a correspondent for CBS News and Stations, contributing to ...

BioNTech won’t proceed with further development of its BNT111 cancer vaccine candidate in a specific late-stage refractory melanoma setting, a company spokesperson told Fierce Biotech. The decision to ...

IO102-IO103 plus Keytruda improved median PFS by 8.4 months over Keytruda alone in advanced melanoma patients. The combination therapy showed a significant PFS benefit in PD-L1–negative patients, with ...